Compounds > razoxane
Page last updated: 2024-08-23

razoxane and Leukemia, Lymphocytic

razoxane has been researched along with Leukemia, Lymphocytic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fox, RM; Taylor, IW; Tripp, EH1
Bakowski, MT; Lister, TA; Malpas, JS; McElwain, TJ; Powles, RL; Prentice, HG1

Trials

1 trial(s) available for razoxane and Leukemia, Lymphocytic

ArticleYear
Limited activity of ICRF-159 in advanced acute leukemia.
    Cancer treatment reports, 1979, Volume: 63, Issue:1

    Topics: Clinical Trials as Topic; Cytarabine; Drug Therapy, Combination; Humans; Leukemia; Leukemia, Lymphoid; Piperazines; Razoxane

1979

Other Studies

1 other study(ies) available for razoxane and Leukemia, Lymphocytic

ArticleYear
Analytical DNA flow cytometric analysis of deoxyadenosine toxicity in cultured human leukemic lymphoblasts.
    Molecular pharmacology, 1984, Volume: 26, Issue:2

    Topics: Benzimidazoles; Cell Cycle; Cell Line; Deoxyadenosines; DNA, Neoplasm; Flow Cytometry; Fluorescent Dyes; Humans; Leukemia, Lymphoid; Razoxane; T-Lymphocytes

1984